Synairgen Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Selling, General & Admin	2.72	3.76	5.36	5.01	2.25
Research & Development	5.61	6.53	14.94	52.86	15.5
Operating Expenses	8.32	10.29	20.3	57.87	17.74
Operating Income	-8.32	-10.29	-20.3	-57.87	-17.74
Interest Expense	-	-	-	-0	-0.01
Interest & Investment Income	0.4	0.64	0.21	0.01	0.02
Pretax Income	-7.93	-9.66	-20.09	-57.86	-17.73
Income Tax Expense	-1.12	-1.25	-2.45	-9.19	-3.82
Net Income	-6.81	-8.41	-17.65	-48.66	-13.92
Net Income to Common	-6.81	-8.41	-17.65	-48.66	-13.92
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	202	201	201	200	147
Shares Outstanding (Diluted)	202	201	201	200	147
Shares Change	0.11%	0.01%	0.46%	36.24%	34.44%
EPS (Basic)	-0.03	-0.04	-0.09	-0.24	-0.09
EPS (Diluted)	-0.03	-0.04	-0.09	-0.24	-0.09
EPS Growth	-	-	-	-	-
Free Cash Flow	-7.9	-8.23	-14.29	-41.03	-23.86
Free Cash Flow Per Share	-0.04	-0.04	-0.07	-0.20	-0.16
EBITDA	-8.29	-10.21	-20.2	-57.77	-17.64
D&A For EBITDA	0.03	0.08	0.1	0.1	0.1
EBIT	-8.32	-10.29	-20.3	-57.87	-17.74